Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 8, 2024
Accession Number:
0001193125-24-061871
Submission Type:
POS AM
CIK:
0001990550
Company Name:
Ambrx Biopharma, Inc.
File Number:
333-275053